NYSEARCA:IVOGVanguard S&P Mid-Cap 400 Growth ETF Stock Price, Forecast & News

Vanguard S&P Mid-Cap 400 Growth ETF's stock was trading at $118.89 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization (WHO). Since then, IVOG shares have increased by 11.4% and is now trading at $132.4440. View which stocks have been most impacted by Coronavirus.

Vanguard S&P Mid-Cap 400 Growth ETF announced an annual dividend on Monday, December 16th. Investors of record on Tuesday, December 17th will be given a dividend of $1.7219 per share on Thursday, December 19th. This represents a dividend yield of 1.2%. The ex-dividend date of this dividend is Monday, December 16th. This is an increase from Vanguard S&P Mid-Cap 400 Growth ETF's previous annual dividend of $1.19. View Vanguard S&P Mid-Cap 400 Growth ETF's dividend history.

Media coverage about IVOG stock has trended negative recently, InfoTrie Sentiment Analysis reports. The research firm ranks the sentiment of press coverage by monitoring more than six thousand news and blog sources. The firm ranks coverage of public companies on a scale of -5 to 5, with scores closest to five being the most favorable. Vanguard S&P Mid-Cap 400 Growth ETF earned a media sentiment score of -2.8 on InfoTrie's scale. They also assigned headlines about the company a news buzz of 0.0 out of 10, indicating that recent press coverage is extremely unlikely to have an impact on the stock's share price in the immediate future. View the latest news aboutVanguard S&P Mid-Cap 400 Growth ETF.

Based on aggregate information from My MarketBeat watchlists, some companies that other Vanguard S&P Mid-Cap 400 Growth ETF investors own include BlackRock Science & Technology Trust (BST), SPDR Gold Shares (GLD), Johnson & Johnson (JNJ), Adobe (ADBE), CNX Midstream Partners (CNXM), Lam Research (LRCX), Lululemon Athletica (LULU), Mastercard (MA), Netflix (NFLX) and SPDR S&P 500 ETF Trust (SPY).

Vanguard S&P Mid-Cap 400 Growth ETF trades on the New York Stock Exchange (NYSE)ARCA under the ticker symbol "IVOG."

Vanguard S&P Mid-Cap 400 Growth ETF's stock is owned by a number of retail and institutional investors. Top institutional investors include Stordahl Capital Management Inc. (1.29%), Morgan Stanley (0.81%), UBS Group AG (0.58%), Wells Fargo & Company MN (0.46%), Jane Street Group LLC (0.37%) and Relaxing Retirement Coach (0.35%).

IVOG stock was sold by a variety of institutional investors in the last quarter, including Adviser Investments LLC, MML Investors Services LLC, Cambridge Investment Research Advisors Inc., Relaxing Retirement Coach, UBS Group AG, Morgan Stanley, EP Wealth Advisors LLC, and Commonwealth Equity Services LLC.

IVOG stock was purchased by a variety of institutional investors in the last quarter, including Jane Street Group LLC, Tower Research Capital LLC TRC , Advisor Group Holdings Inc., Ziegler Capital Management LLC, PNC Financial Services Group Inc., Stordahl Capital Management Inc., Golden State Wealth Management LLC, and Rockefeller Capital Management L.P..

Shares of IVOG can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

One share of IVOG stock can currently be purchased for approximately $132.44.

Vanguard S&P Mid-Cap 400 Growth ETF has a market capitalization of $668.84 million.